STERIS plc

STE · Healthcare

$214.40
+1.73% today

What a holder would want to know before buying STE: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $199.40 · Jun 2026High $268.65 · Jan 2026

Today’s price is 8% above the lowest point of the past year and 20% below the highest.

Over the past year it was cheaper than today on 25% of days and more expensive on 75%. Over the last 10 years: cheaper on 66% of days.

6% below its average price of the last 200 trading days.

How bad does it get

Fell 20% or more 3 times in 10 years. The deepest fall was 36%; the longest took 3.5 years to get back to its peak. 2 of 3 have recovered so far.

It is in one now: 20% below the Jan 2026 peak.

Jan 2026
−26%not back yet
Apr 2022
−36%back in 3.5 years
Feb 2020
−36%back in 7 months
What you own

STERIS plc · Healthcare · Medical Devices · a large company worth $20.90B

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.…

Is it making money?
2023
2024
2025
2026

revenue profit

Sales of $5.94B in 2026, with $782.30M of profit. Sales grew in 3 of the last 3 years.

Keeps about 13 cents of every dollar of sales as profit.

Is it healthy?
Cash
$482.30M
Debt
$2.04B
Free cash flow / yr
$798.86M

Would need about 2.6 years of free cash flow to repay all its debt.

Is it expensive?

You pay $26 for every $1 of last year’s profit, and $18 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays 1.22% a year in dividends at today’s price · next ex-dividend Sep 4.

What others are doing

9 analysts: 7 say buy, 2 hold, 0 sell. Their average 12-month target is $263.13 (range $232.00–$280.00).

Insiders made 0 purchases and 4 sales in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy STE with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.